31.08.2013 Views

Apixaban for the prevention of venous thromboembolism in people ...

Apixaban for the prevention of venous thromboembolism in people ...

Apixaban for the prevention of venous thromboembolism in people ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Table 5.11 Adm<strong>in</strong>istration costs Enoxapar<strong>in</strong> (Table 71 MS-page 167)<br />

Number<br />

<strong>of</strong><br />

blood<br />

counts<br />

Cost<br />

<strong>of</strong><br />

blood<br />

count<br />

@<br />

Cost <strong>of</strong> nurse<br />

tra<strong>in</strong><strong>in</strong>g<br />

<strong>for</strong><br />

30 m<strong>in</strong>utes<br />

*<br />

4 £10.11 £25.00<br />

(87% <strong>of</strong><br />

patients)<br />

Home visits<br />

from a<br />

community<br />

nurse<br />

to <strong>in</strong>ject<br />

prophylaxis<br />

13%<br />

<strong>of</strong> patients<br />

50<br />

Number <strong>of</strong><br />

days where<br />

home visit is<br />

required<br />

¥<br />

Community<br />

nurse<br />

#<br />

Total<br />

TKR THR TKR THR<br />

7 29 £27.00 £86.76 £163.98<br />

@unit cost taken from <strong>the</strong> rivaroxaban STA submission to NICE 49 and updated to 2008/9 costs us<strong>in</strong>g <strong>the</strong> Hospital and<br />

Community Health Service Pay and Price Index 61 (See Appendix 19 MS); *(24-hour ward [costs <strong>in</strong>clud<strong>in</strong>g qualifications]) 61<br />

¥Treatment duration m<strong>in</strong>us <strong>in</strong>patient stay. #(<strong>in</strong>cludes district nurs<strong>in</strong>g sister, district nurse) - home visit (<strong>in</strong>clud<strong>in</strong>g wages/salary,<br />

salary oncosts, qualifications, overheads, capital overheads and travel) 61<br />

Health state costs and costs <strong>of</strong> events<br />

The PE cost comprises <strong>of</strong> <strong>the</strong> cost <strong>of</strong> treat<strong>in</strong>g PE that occurs dur<strong>in</strong>g TKR or THR surgery and<br />

follow<strong>in</strong>g discharge weighted by <strong>the</strong> proportion experienc<strong>in</strong>g each event. 63 All Patients<br />

experienc<strong>in</strong>g PE follow<strong>in</strong>g discharge were assumed to be re-hospitalised.<br />

Distal DVT costs comprised <strong>of</strong> <strong>the</strong> cost <strong>of</strong> treat<strong>in</strong>g Distal DVT that occurs dur<strong>in</strong>g TKR or<br />

THR surgery weighted by <strong>the</strong> proportion <strong>of</strong> patients experienc<strong>in</strong>g this event 63 as an <strong>in</strong>patient,<br />

plus <strong>the</strong> cost <strong>of</strong> treat<strong>in</strong>g <strong>the</strong> cost <strong>of</strong> distal DVT as an outpatient and readmission weighted by<br />

42, 63<br />

<strong>the</strong> proportion <strong>of</strong> patients experienc<strong>in</strong>g each <strong>for</strong>m <strong>of</strong> treatment.<br />

Proximal DVT costs comprised <strong>of</strong> <strong>the</strong> cost <strong>of</strong> treat<strong>in</strong>g Distal DVT that occurs dur<strong>in</strong>g TKR or<br />

THR surgery weighted by <strong>the</strong> proportion <strong>of</strong> patients experienc<strong>in</strong>g this event 63 as an <strong>in</strong>patient,<br />

plus <strong>the</strong> cost <strong>of</strong> treat<strong>in</strong>g <strong>the</strong> cost <strong>of</strong> proximal DVT as an outpatient and readmission weighted<br />

42, 63<br />

by <strong>the</strong> proportion <strong>of</strong> patients experienc<strong>in</strong>g each <strong>for</strong>m <strong>of</strong> treatment.<br />

The long term costs, costs applied <strong>in</strong> <strong>the</strong> long term Markov model, <strong>for</strong> PE, DVT, mild to<br />

moderate PTS (year 1/first <strong>in</strong>stance and subsequent years) and severe PTS (year 1/first<br />

<strong>in</strong>stance and subsequent years) were taken from Cohen et al. 2001 64 and <strong>in</strong>flated to 2008/09<br />

costs us<strong>in</strong>g <strong>the</strong> Hospital and Community Health Services Pay and Price Index. 61 The cost <strong>of</strong><br />

car<strong>in</strong>g <strong>for</strong> and treat<strong>in</strong>g disabled patients was taken from Youman et al. 65 and <strong>in</strong>flated to<br />

2008/09 us<strong>in</strong>g <strong>the</strong> Hospital and Community Health Services Pay and Price Index. 61<br />

Copyright 2011 Queen’s Pr<strong>in</strong>ter and Controller <strong>of</strong> HMSO. All rights reserved.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!